Osiris Therapeutics, Inc. (OSIR) Tops Q4 EPS by 4c

March 9, 2012 8:01 AM EST
Osiris Therapeutics, Inc. (NASDAQ: OSIR) reported Q4 EPS of $0.15, $0.04 better than the analyst estimate of $0.11. Revenue for the quarter came in at $10.28 million versus the consensus estimate of $10.68 million.

For earnings history and earnings-related data on Osiris Therapeutics, Inc. (OSIR) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings